Literature DB >> 15043800

Hemifacial Spasm.

Lawrence W. Kemp1, Stephen G. Reich.   

Abstract

Hemifacial spasm (HFS) is a peripheral movement disorder caused by direct or indirect compression or distortion of the root exit zone of the seventh cranial nerve, which is most commonly compressed by an arterial loop, but also may be compressed by a tumor, cyst, or aneurysm. All patients with HFS should undergo magnetic resonance imaging, with particular attention to the seventh cranial nerve. For patients with HFS who want treatment, there are three options. Oral medications, particularly anticonvulsants, may be useful, but the response rate is low and evidence is almost exclusively anecdotal. Local injection of botulinum toxin into the overactive muscles has a very high rate of success and virtually no serious side effects. Backed by controlled clinical trials, the authors consider it the treatment of choice. Microvascular surgical decompression has the advantage of being potentially curative, and obviates the need for chronic injections with botulinum toxin. However, surgery carries much greater risk than botulinum toxin and the spasm may recur. It is important that surgery is carried out by an experienced neurosurgeon to reduce the risk.

Entities:  

Year:  2004        PMID: 15043800     DOI: 10.1007/s11940-004-0009-4

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  34 in total

Review 1.  Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm.

Authors:  W H Jost; A Kohl
Journal:  J Neurol       Date:  2001-04       Impact factor: 4.849

2.  Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period.

Authors:  G-Y R Hsiung; S K Das; R Ranawaya; A-L Lafontaine; O Suchowersky
Journal:  Mov Disord       Date:  2002-11       Impact factor: 10.338

3.  Etiology and definitive microsurgical treatment of hemifacial spasm. Operative techniques and results in 47 patients.

Authors:  P J Jannetta; M Abbasy; J C Maroon; F M Ramos; M S Albin
Journal:  J Neurosurg       Date:  1977-09       Impact factor: 5.115

Review 4.  Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases.

Authors:  S Jitpimolmard; S Tiamkao; M Laopaiboon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-06       Impact factor: 10.154

Review 5.  Electrophysiology of the facial nerve in hemifacial spasm: ectopic/ephaptic excitation.

Authors:  V K Nielsen
Journal:  Muscle Nerve       Date:  1985-09       Impact factor: 3.217

6.  Hemifacial spasm in Rochester and Olmsted County, Minnesota, 1960 to 1984.

Authors:  R G Auger; J P Whisnant
Journal:  Arch Neurol       Date:  1990-11

7.  Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.

Authors:  J Jankovic; K Schwartz; D T Donovan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

8.  Baclofen in hemifacial spasm.

Authors:  R Sandyk; M A Gillman
Journal:  Int J Neurosci       Date:  1987-04       Impact factor: 2.292

9.  Hemifacial spasm: clinical findings and treatment.

Authors:  A Wang; J Jankovic
Journal:  Muscle Nerve       Date:  1998-12       Impact factor: 3.217

10.  Microvascular decompression for hemifacial spasm.

Authors:  F G Barker; P J Jannetta; D J Bissonette; P T Shields; M V Larkins; H D Jho
Journal:  J Neurosurg       Date:  1995-02       Impact factor: 5.115

View more
  10 in total

1.  Prognostic factors of hemifacial spasm after microvascular decompression.

Authors:  Hong Rae Kim; Deok-Joo Rhee; Doo-Sik Kong; Kwan Park
Journal:  J Korean Neurosurg Soc       Date:  2009-06-30

2.  Microsurgical treatment for 55 patients with hemifacial spasm due to cerebellopontine angle tumors.

Authors:  Hongyan Han; Guoqiang Chen; Huancong Zuo
Journal:  Neurosurg Rev       Date:  2010-03-09       Impact factor: 3.042

3.  Atypical hemifacial spasm due to vertebral artery dolichoectasia: rare cause of a rarer clinical entity.

Authors:  Tarun Mathur; Trilochan Srivastava; Vijay Sardana; Rahul Jain
Journal:  BMJ Case Rep       Date:  2013-07-10

Review 4.  Hemifacial spasm and neurovascular compression.

Authors:  Alex Y Lu; Jacky T Yeung; Jason L Gerrard; Elias M Michaelides; Raymond F Sekula; Ketan R Bulsara
Journal:  ScientificWorldJournal       Date:  2014-10-28

5.  Hemifacial spasm in a patient with basilar artery dolichoectasia caused by uncontrolled hypertension.

Authors:  Gordon S Crabtree; David Gish; David Goldberg
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-10-26

6.  Methicillin-resistant Staphylococcus aureus Meningitis as a Complication of Facial Nerve Decompression for Vertebrobasilar Dolichoectasia.

Authors:  Yash Jobanputra; Purva Sharma; Sean J Martinez
Journal:  Cureus       Date:  2018-10-01

7.  Neurologic uses of botulinum neurotoxin type A.

Authors:  John P Ney; Kevin R Joseph
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

8.  CPAP Therapy Improves Intractable Hemifacial Spasm.

Authors:  Narongrit Kasemsap; Sittichai Netwijitpan; Panita Limpawattana; Kannikar Kongbunkiat; Somsak Tiamkao; Verajit Chotmongkol; Noppadol Aekphachaisawat; Kittisak Sawanyawisuth
Journal:  Case Rep Neurol Med       Date:  2015-10-15

9.  Acupuncture therapy for patients with hemifacial spasm: A protocol of systematic review and meta-analysis.

Authors:  Han Yang; Jun Zhou; Dongling Zhong; Zihan Yin; Guixing Xu; Jiao Chen; Juan Li; Fanrong Liang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

10.  Efficacy of fire needle on patients of facial spasm: A protocol for systematic review and meta analysis.

Authors:  Zhiying Zhong; Jun Xiong; Lunbin Lu; Jun Chen; Genhua Tang; Siyuan Zhu; Xingchen Zhou; Han Guo
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.